<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03861520</url>
  </required_header>
  <id_info>
    <org_study_id>12019</org_study_id>
    <nct_id>NCT03861520</nct_id>
  </id_info>
  <brief_title>Ultrasonographic Fetal Soft Markers and Aneuploidy</brief_title>
  <official_title>Correlation Between Ultrasonographic Fetal Soft Markers and Aneuploidy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the prevalence of soft markers which will be
      identified during a second trimester ultrasound. Secondary aims were to estimate the
      association between the soft markers and trisomies 13, 18 and 21 as well as the effect on the
      number of invasive tests will be performed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 14, 2019</start_date>
  <completion_date type="Actual">April 5, 2020</completion_date>
  <primary_completion_date type="Actual">April 5, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To study the association between soft markers identified at second trimester ultrasound and aneuploidy.</measure>
    <time_frame>1 year</time_frame>
    <description>fetal soft markers detection which include the following:
choroid plexus cyst.
Mild ventriculomegaly.
Enlarged cistern magna.
Nasal bone hypoplasia.
Increased nuchal fold.
Echogenic cardiac focus.
Single umbilical artery.
Pyelectasis.
Echogenic bowl.
Short femur.
Short humerus.
All data will be collected and statistics will be done for the correlation between one or more soft markers with structural anomalies and its relation with aneuploidy.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Soft Markers</condition>
  <arm_group>
    <arm_group_label>16-24 weeks Pregnant womes</arm_group_label>
    <description>Pregnant Women at (16-24) weeks of gestation for mid trimester anomaly scan with one sonographic fetal soft marker or more.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Midtrimester anomaly scan</intervention_name>
    <description>A detailed anomaly scan to detect soft markers at 16 to 24 weeks pregnancy</description>
    <arm_group_label>16-24 weeks Pregnant womes</arm_group_label>
    <other_name>2nd trimester anomaly scan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Fetal Karyotyping</intervention_name>
    <description>Fetal karyotyping after birth to confirm chromosomal anomaly diagnosed clinically</description>
    <arm_group_label>16-24 weeks Pregnant womes</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Fetal karyotyping
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant Women at (16-24) weeks of gestation for mid trimester anomaly scan with one
        sonographic fetal soft marker or more
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. pregnant woman between (16-24) weeks of gestation.

          2. singelton pregnancy.

        Exclusion Criteria:

          1. Multiple pregnancies.

          2. Mental condition rendering the patients unable to understand the nature and scope of
             the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maha M Mossad, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 28, 2019</study_first_submitted>
  <study_first_submitted_qc>March 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2019</study_first_posted>
  <last_update_submitted>April 5, 2020</last_update_submitted>
  <last_update_submitted_qc>April 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Yasmin Ahmed Bassiouny</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Anomaly scan</keyword>
  <keyword>Anuploidy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneuploidy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

